Hospital Denial Rates: Benchmarks, Trends & What the Data Shows (2026)
Hospital claim denials represent one of the most significant operational and financial challenges facing healthcare providers in 2026, driving $48.4 billion in revenue leakage in 2025 alone. As payers tighten utilization management protocols and expand prior authorization requirements, hospitals are navigating an increasingly complex reimbursement landscape. While many hospitals focus denial management efforts after claims are rejected, technology-enabled, physician-directed pre-bill review programs are increasingly being used to identify documentation gaps before submission, strengthen claim defensibility, and support more successful denial appeals when they occur. n. This piece examines the most recent healthcare claim denial statistics to benchmark current denial rates, identify which payer categories pose the greatest challenges, and quantify the financial impact on hospital revenue cycles as we move deeper into 2026.
Methodology: Our analysis draws primarily from 2025 claims performance data published by Kodiak Solutions (based on aggregated data from 2,300+ hospitals and 375,000 physicians) and Experian Health’s 2025 State of Claims survey of 250 revenue cycle leaders. Where relevant, 2024 comparative benchmarks are included to show year-over-year trends.
Overall Hospital Denial Rates: 2025 Trends
Understanding industry-wide denial trends provides essential context for benchmarking individual hospital performance and identifying areas for improvement.
Overall Hospital Denial Rates (2024-2025)
Source: Kodiak Solutions, State of the Healthcare Revenue Cycle (March 2026) [1,2]
| Metric | 2024 | 2025 | Change |
| Initial Denial Rate (Overall) | 11.4% | 11.6% | +0.2 pp |
| Clinical Initial Denial Rate | 2.4% | 2.6% | +0.2 pp |
| RFI Initial Denial Rate | 3.4% | 3.6% | +0.2 pp |
| Final Denial Rate | 2.5% | 2.7% | +0.2 pp |
Key Takeaways:
- Denial rates are rising across all categories: Every tracked metric increased by 0.2 percentage points year-over-year, signaling sustained pressure on revenue cycle operations despite increased appeals and rework efforts.
- Initial denial rates remain almost four times higher than final rates: The gap between initial and final denials demonstrates that many claims are ultimately paid after appeals, but the administrative burden and cash flow delays create significant operational costs for hospitals.
- Clinical denials increased 8.3% year-over-year: The jump to 2.6% represents one of the steeper relative increases, suggesting payers are scrutinizing medical necessity and clinical documentation more aggressively than in prior years.
- Request-for-information denials also climbed: RFI denials rose to 3.6%, indicating that incomplete documentation remains a persistent challenge even as hospitals invest in CDI programs and pre-submission quality checks.
Inpatient Denial Rates by Payer: 2025 Performance
Payer mix significantly influences a hospital’s overall denial rate, with inpatient claims showing substantial variation across government and commercial insurance categories.
Inpatient Denial Rates by Payer (2025)
Source: Kodiak Solutions, State of the Healthcare Revenue Cycle (March 2026) [1]
| Payer Type | Initial Denial Rate | Final Denial Rate |
| Medicaid | 44% | 6% |
| Commercial | 21% | 3% |
| Managed Medicaid | 18% | 4% |
| Medicare Advantage | 11% | 5% |
| Medicare (Traditional) | 5% | 1% |
Key Takeaways:
- Medicaid inpatient denials are the highest across all payers: At 44% initial denial rate, Medicaid rejects nearly half of all inpatient claims on first submission, creating substantial administrative burden and cash flow challenges for safety-net hospitals serve high Medicaid populations.Physician-led pre-bill chart reviews can help identify documentation gaps before claims are submitted, enabling stronger appeal letters and improving the likelihood of overturning denials
- Traditional Medicare maintains the lowest denial rate: With just 5% initial denials and 1% final denials, fee-for-service Medicare remains the most predictable and straightforward payer for inpatient claims.
- Commercial payers deny inpatient claims at more than four times the rate of Medicare: The 21% initial denial rate for commercial insurance reflects aggressive prior authorization requirements and medical necessity reviews, particularly for high-cost inpatient procedures and admissions.
- Final denial rates drop significantly after appeals: Medicaid’s final denial rate of 6% (down from 44% initial) and commercial’s 3% final rate (down from 21% initial) show that most denials are administrative or documentation-related rather than true coverage denials, though the rework costs are substantial.
Financial Impact of Claim Denials
The revenue implications of rising denial rates extend beyond individual claims to create system-wide financial pressure for hospitals.
Financial Impact of Claim Denials
| Metric | Value | Source |
| Total revenue leakage (2025) | $48.4 billion | Kodiak [2] |
| Revenue leakage increase (2024-2025) | +25% | Kodiak [2] |
| Median bad debt rate (2025) | 1.3% | Kodiak [1] |
| Commercial inpatient net revenue leakage (2025) | 6.6% | Kodiak [3] |
| Commercial outpatient net revenue leakage (2025) | 10.3% | Kodiak [3] |
| Providers reporting ≥10% denial rate | 41% | Experian [4] |
| RCM leaders reporting rising claim errors | 54% | Experian [4] |
Key Takeaways:
- Revenue leakage grew faster than denial rates: Net revenue leakage increased 25% from $38.6 billion in 2024 to $48.4 billion in 2025, suggesting that denial management complexity and resolution costs have increased even more than denial volume.
- Commercial outpatient leakage is higher than inpatient despite lower denial rates: The 10.3% net revenue leakage for commercial outpatient claims (versus 6.6% for inpatient) indicates that outpatient denials are more likely to result in write-offs or remain unresolved, possibly due to lower dollar values making appeals less cost-effective.
- More than half of revenue cycle leaders see worsening trends: The 54% of RCM leaders reporting rising claim errors and 41% reporting that at least one in ten claims are denied reflect widespread concern about denial management heading into 2026.
- Bad debt and final denials together strain hospital margins: The 1.3% median bad debt rate combined with the 2.7% final denial rate means hospitals are losing nearly 4% of expected revenue to uncollectible claims and unresolved denials, a significant margin hit in an already thin-margin industry.
The Top 9 Reasons for Claim Denials
Understanding why claims are denied is the first step toward prevention. Revenue cycle leaders identify seven primary denial categories, most of which are preventable with better front-end processes and clinical documentation.
Source: Experian Health, State of Claims Report 2025 [4]
1. Missing or inaccurate data: Incomplete patient information, missing prior authorization numbers, or incorrect billing codes remain the single most common denial reason. These administrative errors are typically caught during payer adjudication and require claim resubmission with corrected information.
2. Prior authorization issues: Claims submitted without obtaining required prior authorization, or with authorizations that expired before service dates, are routinely denied. Payers have expanded prior authorization requirements significantly in recent years, particularly for imaging, procedures, and specialty services.
3. Inaccurate or incomplete patient information: Eligibility verification failures, incorrect patient addresses, outdated insurance information, or subscriber ID errors lead to denials that are preventable through better registration and intake processes at the point of service.
4. Coding errors: Incorrect procedure codes, diagnosis codes that don’t support medical necessity, unbundling errors, or use of outdated code sets trigger denials that require recoding and resubmission. These often result from insufficient clinical documentation or coder training gaps.
5. Clinical validation denials: Claims denied when a diagnosis may be coded correctly, but the payer argues the medical record lacks sufficient clinical evidence to support the condition documented by the physician. These denials commonly target high-impact diagnoses affecting DRG assignment, severity of illness, and reimbursement. Successfully defending them often requires physician-led clinical review, strong documentation integrity practices, and detailed appeals grounded in clinical evidence and established criteria.
6. Medical necessity denials: Claims denied because payers determine inpatient admission, level of care, or specific services were not medically necessary based on documentation submitted. These denials often require detailed clinical justification, physician advisor involvement, peer-to-peer reviews, or formal appeals to demonstrate that the patient met inpatient admission criteria and severity-of-illness standards.
7. Services not covered: Claims for services excluded under the patient’s specific plan, experimental treatments, or procedures deemed not medically necessary by the payer are denied. These denials are often difficult to overturn and may require additional clinical rationale or contract review.
8. Eligibility verification issues: Claims denied because coverage was terminated, patients were never eligible, or services were provided outside the coverage period. Real-time eligibility checking at registration can prevent most of these denials.
9. Staff shortages: Revenue cycle leaders cite staffing challenges as an emerging denial driver, with insufficient personnel leading to rushed intake processes, delayed follow-up on pending claims, and less thorough pre-submission quality reviews.
The pattern across these seven categories is clear: most denials are preventable through stronger front-end processes, better real-time eligibility verification, and improved clinical documentation at the point of care. Payers are not relaxing utilization management or authorization requirements; hospitals must instead focus on submission accuracy and complete documentation to reduce initial denial rates.
Why Hospitals Are Taking a More Proactive Approach to Denial Prevention
For many health systems, denial management has historically been reactive: claims are denied, teams appeal them, and reimbursement is recovered weeks or months later. But as denial rates rise and payer scrutiny becomes more aggressive, hospitals are increasingly shifting focus toward denial prevention strategies that address documentation and clinical defensibility before claims are submitted.
This is particularly important for clinical validation and medical necessity denials, where the issue is often not coding accuracy alone, but whether the medical record clearly supports the physician’s documented diagnoses, severity of illness, or inpatient status determination.
At Enjoin, physician-directed pre-bill review programs are designed to identify these vulnerabilities before claims reach the payer. Unlike technology-only approaches that rely solely on automated edits or retrospective analytics, Enjoin combines advanced prioritization technology with physician-led clinical review to evaluate documentation integrity, DRG accuracy, medical necessity support, and appeal defensibility in real time.
This approach allows hospitals to:
- Identify high-risk claims before billing submission
- Reduce preventable denials tied to documentation gaps
- Strengthen clinical validation and medical necessity support
- Improve appeal success rates through physician-backed rationale
- Reduce administrative rework and downstream revenue leakage
- Support coders, CDI teams, and physician advisors with scalable workflows
In many organizations, denial trends also reveal broader operational challenges beyond individual claims. Patterns tied to specific payers, service lines, diagnoses, or documentation workflows can expose opportunities for physician education, CDI optimization, and front-end process improvement.
Because of this, denial management is increasingly becoming a strategic revenue integrity initiative rather than simply an appeals function.
Hospitals investing in physician-directed documentation review, concurrent CDI strategies, and proactive denial prevention workflows are often better positioned to protect reimbursement, improve operational efficiency, and reduce long-term revenue leakage as payer scrutiny continues to intensify throughout 2026.
Looking Ahead: 2026 Denial Management Outlook
As the healthcare reimbursement landscape continues to evolve throughout 2026, ongoing monitoring of denial trends will be critical for revenue cycle leaders. Payer utilization management strategies, regulatory changes, and economic pressures on both hospitals and insurers will shape whether the upward trajectory observed in 2024-2025 continues or stabilizes in the coming quarters. Organizations investing in proactive clinical documentation programs and denial prevention strategies will be better positioned to navigate these challenges.
Sources
[1] Kodiak Solutions. “State of the Healthcare Revenue Cycle.” March 2026. https://www.kodiaksolutions.io/internal/benchmarking_reports/march_2026_benchmarking_intelligence_report
[2] TechTarget. “Hospitals lost over $48B from claims denials, uncollected bills.” April 2026. https://www.techtarget.com/revcyclemanagement/news/366641065/Hospitals-lost-over-48B-from-claims-denials-uncollected-bills
[3] Employer Coverage. “Insurance denial rates increased in 2025.” 2026. https://employercoverage.substack.com/p/insurance-denial-rates-increased
[4] Experian Health. “Healthcare claim denial statistics: State of Claims Report 2025.” October 2025. https://www.experian.com/blogs/healthcare/healthcare-claim-denials-statistics-state-of-claims-report/